RankAlpha logo
Back to Rankings

IPHA

InnateF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-15
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
IPHA vs peer average
20/100
IPHA vs. peer average (F vs. C)
Grade spread
A 2 · B 1 · C 1 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

SPRO is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $168.49M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerSPROSpero Therapeutics
IPHA
Innate
SPRO
Spero Therapeutics
Grade
F
F
Momentum
18
5
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs SPRO

IPHA / SPRO
Grade Position
Below peers
IPHA vs. peer average (F vs. C)
20/100
Momentum
18
IPHA
Value
41
IPHA
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IPHA
1
SPRO
Spero Therapeutics Inc Common
F
20/100
Even
2
ABOS
Acumen Pharmaceuticals Inc Common
A
100/100
-4
3
ACB
Aurora Cannabis Inc Common
C
60/100
-2
4
KRRO
Korro Bio Inc Common
D
40/100
-1
5
NMRA
Neumora Therapeutics Inc Common
A
100/100
-4
SPRO is the first peer returned for this comparison set.